Published in Virology on November 01, 1992
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci U S A (1998) 2.22
The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol (1997) 2.06
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol (2002) 1.53
A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J Virol (2000) 1.48
Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol (2005) 1.48
Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest (1995) 1.47
The pseudorabies virus US3 protein is a component of primary and of mature virions. J Virol (2004) 1.39
Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole. J Virol (1999) 1.39
Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol (2001) 1.37
Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94. J Virol (2002) 1.30
The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. J Virol (1996) 1.29
Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J Virol (1999) 1.27
Conserved herpesvirus protein kinases. Biochim Biophys Acta (2007) 1.17
Phosphorylation and nuclear localization of the varicella-zoster virus gene 63 protein. J Virol (1996) 1.14
Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J Virol (1999) 1.13
Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J Virol (1998) 1.08
Viral serine/threonine protein kinases. J Virol (2010) 0.99
The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J Virol (1999) 0.97
Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. Antimicrob Agents Chemother (1996) 0.83
Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells. J Virol (2016) 0.75
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
Partner's influence on patient preference for treatment in early prostate cancer. BJU Int (2003) 2.33
Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment. J Virol (1988) 2.22
Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun (1978) 2.15
Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J Virol (1997) 2.14
Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol (1985) 2.09
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology (2000) 1.99
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol (1995) 1.89
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology (1980) 1.72
Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology (1995) 1.72
Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics (1981) 1.69
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J Virol (1998) 1.62
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J Virol (1993) 1.58
Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J (1990) 1.53
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53
Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology (2001) 1.50
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl (1992) 1.49
Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol (1996) 1.49
Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology (1994) 1.46
Pyomyositis in an adolescent female athlete. J Pediatr Surg (1995) 1.43
Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis (1979) 1.40
Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. J Virol (1993) 1.40
Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology (2006) 1.39
Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J Infect Dis (1983) 1.39
Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol (2001) 1.37
Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology (1993) 1.36
Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain. Virology (1998) 1.35
Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J Virol (2001) 1.29
Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology (1990) 1.29
Interactions among structural proteins of varicella zoster virus. Arch Virol Suppl (2001) 1.27
Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology (1986) 1.23
Chaperone functions common to nonhomologous Epstein-Barr virus gL and Varicella-Zoster virus gL proteins. J Virol (1997) 1.18
Varicella zoster virus glycoprotein gpI is selectively phosphorylated by a virus-induced protein kinase. Proc Natl Acad Sci U S A (1986) 1.18
Bell's palsy and infectious mononucleosis. Lancet (1973) 1.17
Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J Immunol (1986) 1.15
Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J Virol (1999) 1.13
Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation. J Infect Dis (1984) 1.13
Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex). J Virol (1994) 1.13
Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). J Virol (1987) 1.07
Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins. J Virol (1985) 1.03
Epstein-Barr virus and Guillain-Barré syndrome. Lancet (1972) 1.03
Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. Am J Ophthalmol (1992) 1.02
Cryopreservation of varicella-zoster virions without loss of structural integrity or infectivity. Intervirology (1981) 1.02
Immunoprecipitable polypeptides specified by varicella-zoster virus. Virology (1982) 1.01
Varicella-zoster virus p32/p36 complex is present in both the viral capsid and the nuclear matrix of the infected cell. J Virol (1986) 1.00
Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus. Infect Immun (1981) 0.99
Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. J Infect Dis (1989) 0.98
Purification and molecular anatomy of the varicella-zoster virion. Biken J (1983) 0.96
Zoster in children with cancer: radioimmune precipitation profiles of sera before and after illness. J Infect Dis (1983) 0.95
Varicella-zoster viral glycoprotein envelopment: ultrastructural cytochemical localization. J Histochem Cytochem (1986) 0.95
Epitope mapping and tagging by recombination PCR mutagenesis. Biotechniques (1997) 0.95
Varicella-zoster virus glycoprotein gE: endocytosis and trafficking of the Fc receptor. J Infect Dis (1998) 0.93
Mechanism of selective nonspecific cell-mediated cytotoxicity of virus-infected cells. Nature (1976) 0.92
Primary Epstein-Barr virus infection in a renal transplant recipient. South Med J (1977) 0.92
Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography. J Virol (1984) 0.91
Immunization of inbred guinea pigs with varicella-zoster virus grown in a syngeneic transformed embryo cell line. J Clin Microbiol (1981) 0.90
DNA mapping of paired varicella-zoster virus isolates from patients with shingles. Lancet (1983) 0.89
Transformation of primary chick embryo fibroblasts by Marek's disease virus. Virology (1997) 0.88
Genomic analysis of varicella-zoster virus: primers for individual open reading frames. J Clin Virol (2003) 0.88
Cerebroside antibody titers in antisera capable of myelination inhibition and demyelination. Brain Res (1978) 0.86
Pyomyositis presenting as acute abdominal pain. Pediatr Infect Dis (1984) 0.85
Multimeric humanized varicella-zoster virus antibody fragments to gH neutralize virus while monomeric fragments do not. J Gen Virol (2001) 0.85
Magnetic resonance imaging of the brain in childhood herpesvirus infections. Pediatr Infect Dis J (1987) 0.85
Cellular immunodeficiency associated with nucleoside phosphorylase deficiency. Immunologic and biochemical studies. Clin Immunol Immunopathol (1977) 0.84
Prenatal diagnosis of congenital cytomegalovirus infection by virus isolation from amniotic fluid. Am J Obstet Gynecol (1990) 0.82
Epstein-Barr virus and transverse myelitis. Lancet (1973) 0.82
Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum. J Virol (2009) 0.81
Varicella pneumonitis: immunodiagnosis with a monoclonal antibody. J Pediatr (1984) 0.81
Herpesviral Fc receptors and their relationship to the human Fc receptors. Immunol Res (1992) 0.80
Subacute sclerosing panencephalitis, a measles complication, in an internationally adopted child. Emerg Infect Dis (2000) 0.80
Letter: Measles associated with Bell palsy. Am J Dis Child (1975) 0.79
Bad consequences of bicycle accidents. Pyomyositis. Pediatr Infect Dis J (1994) 0.79
Staphylococcal pyomyositis in South Texas. J Pediatr (1978) 0.79
Guillain-Barré syndrome following administration of live measles vaccine. Am J Med (1976) 0.78
Complete spectrum of the varicella congenital defects syndrome in 5-year-old child. Pediatr Infect Dis (1984) 0.78
Magnetic resonance imaging for early diagnosis of necrotizing fasciitis. Pediatr Emerg Care (1993) 0.78
Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey. Pediatr Infect Dis J (1988) 0.78
Biotinylated and radioactive DNA probes for detection of varicella-zoster virus genome in infected human cells. Mol Cell Probes (1988) 0.78
Fatal pertussis in an Iowa infant. Iowa Med (1991) 0.78
IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination. J Infect Dis (1989) 0.78
Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response. Arch Virol Suppl (2001) 0.77
Prenatal diagnosis of second-trimester congenital varicella syndrome by virus-specific immunoglobulin M. J Pediatr (1987) 0.77
The cell surface in amoeboid locomotion--studies on the role of cell-substrate adhesion. Cell Biol Int Rep (1982) 0.76
Epstein-Barr virus: the hematologic and oncologic consequences of virus-host interaction. Crit Rev Oncol Hematol (1989) 0.76
Pyomyositis in children in the United States. Rev Infect Dis (1991) 0.75
Ceftriaxone vs cefotaxime for treatment of Haemophilus influenzae meningitis. Pediatrics (1990) 0.75
Letter: Atypical measles rash mimicking Rocky Mountain spotted fever. N Engl J Med (1973) 0.75
What's new in pediatrics? Iowa Med (1990) 0.75
Letter: Guillain-Barré syndrome. Am J Dis Child (1974) 0.75
Antimicrobial chemotherapy in the adolescent patient. J Adolesc Health Care (1987) 0.75
Varicella-zoster virus infection of diploid and chemically transformed guinea-pig embryo cells: factors influencing virus replication. J Gen Virol (1981) 0.75
Letter: Facial palsy and infectious mononucleosis. Arch Otolaryngol (1974) 0.75